期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

人博卡病毒病毒样颗粒研究进展 被引量：1

下载PDF
导出
摘要 人博卡病毒（Human Bocavirus，HBoV）是 Allander 等2005年在呼吸道标本大量筛查中发现的一种新病毒，迄今为止 HBoV 共有4个基因型，分别命名为 HBoV1～4。目前HBoV 的致病机制尚未明确，研究结果 HBoV1主要存在于呼吸道分泌物中，引起婴幼儿呼吸道感染；HBoV2-4主要是在粪便标本中被检出，其中 HBoV2及 HBoV3被证实与急性胃肠炎有关，又以 HBoV2的检出率最高。
作者 邓中华 曹友德
机构地区 湖南省人民医院检验科
出处 《国际检验医学杂志》 CAS 2014年第14期1901-1903,共3页 International Journal of Laboratory Medicine
基金 湖南省科技厅科研条件创新专项计划(2012TT2004)
关键词 人博卡病毒 病毒蛋白2 病毒样颗粒
分类号 R373 [医药卫生—病原生物学]
  • 相关文献

参考文献33

  • 1Allander T, Tammi MT, Eriksson M, et al. Cloning of a human parvovirus by molecular screening of respiratory tract samples [J]. Proc Natl Acad Sci U S A,2005,102(36):12891-12896.
  • 2Jartti T, Hedman K,Jartti L,et al. Human bocavirus-the first 5 years[J]. Rev Med Virol,2011,22(1) :46-64.
  • 3Buonaguro L,Tornesello ML, Buonaguro FM. Virus like particles as particulate vaccines[J]. Curt HIV Res,2010,8(4) :299-309.
  • 4Chackerian B. Virus-like particles: flexible platforms for vaccine development[J]. Expert Rev Vaccines,2007,6(3):381 -390.
  • 5Ludwig C, Wagner R. Virus like particles universal molecular toolboxes[J]. Curr Opin Biotechnol, 2007,18(6) : 537-545.
  • 6Grgacic EV, Anderson DA. Virus-like particles: passport to im mune recognition[J]. Methods,2006,40(1) :60- 65.
  • 7Gamvrellis A, Leong D, Hanley JC, et al. Vaccines that facilitate antigen entry into dendritic cells[J]. ImmunoI CeLl Biol, 2004,82 (5) : 506-516.
  • 8Roldao A, Mellado MC, Castilho LR, et al. Virus like particles in vaccine development[J]. Expert Rev Vaccines, 2010,9 (10) : 1149- 1176.
  • 9Paavonen J ,Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial[J]. Lancet,2007,369(9580) :2161- 2170.
  • 10Kee GS, Pujar NS, Titchener Hooker NJ. Study of detergent-me- diated liberation of hepatitis B virus-like particles from S. eerevisi- ae homogenateddentifying a framework for the design of future- generation lipoprotein vaccine processes E J. Biotechnol Prog, 2008,24(3) :623 -631.

二级参考文献29

  • 1卢五迅,程通,李少伟,潘晖榕,沈文通,陈毅歆,张涛,郑舟,张军,夏宁邵.人乳头瘤病毒16型假病毒中和实验的建立和初步应用[J].生物工程学报,2006,22(6):990-995. 被引量：13
  • 2Insinga R P, Dasbach E J, Elbasha E H, et al. Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives[J]. Cancer Epidemiol Biomarkers Prey, 2007, 16(4):709-715.
  • 3Sterling J, Stanley M, Gatward G. Production of human papillomavirus type 16 virions in a keratinocyte cell line [J]. J Virol, 1990,64(12): 6305-6307.
  • 4Zhou J, Sun X Y, Stenzel D J, et al. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virionlike particles[J]. Virology, 1991, 185(1): 251-257.
  • 5Kirnbauer R, Booy F, Cheng N, et al. PapiUomavirus L1 major capsid protein sell-assembles into virus-like particles that are highly immunogenic[J]. Proc Natl Acad Sci U S A, 1992,89(24) : 12180-12184.
  • 6Rose R C, Reichman R C, Bonnez W. Human papillamavirus (HPV) type Ⅱ recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera. J Gen Virol, 1994. 75 (Pt 8): 2075-2079.
  • 7Villa L L, Costa R. L, Petta C A, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase Ⅱ efficacy trial[J]. Lancet Oncol, 2005, 6 (5): 271-278.
  • 8Harper D M, Franco E L, Wheeler C, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial[J]. Lancet, 2004, 364(9447) : 1757-1765.
  • 9Banks L, Matlashewski G, Pim D, et al. Expression of human papillomavirus type 6 and type 16 capsid proteins in bacteria and their antigenic characterization[J]. J Gen Virol, 1987, 68 (Pt 12): 3081-3089.
  • 10Kelsall S R, Kulski, J K. Expression of the major capsid protein of human papillomavirus type 16 in Escherichia coli[J]. J Virol Methods, 1995. 53(1): 75-90.

共引文献12

同被引文献12

引证文献1

二级引证文献3

国际检验医学杂志
2014年 第14期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部